Hormone therapy effects on social behavior and activity levels of surgically postmenopausal cynomolgus monkeys

Psychoneuroendocrinology

Volumn 32, Issue 8-10, 2007, Pages 981-990

  Shively, Carol A ^a   Wood, Charles E ^a   Register, Thomas C ^a   Willard, Stephanie L ^a   Lees, Cynthia J ^a   Chen, Haiying ^a   Sitruk Ware, Regine L ^b   Tsong, Yun Yen ^b   Cline, J Mark ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b POPULATION COUNCIL   (United States)

Author keywords

Activity; Estrogen; Hormone therapy; Medroxyprogesterone acetate; Progesterone; Social behavior

Indexed keywords

ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CROSSING OVER; FEMALE; HEART RATE; HORMONAL THERAPY; MACACA; MONKEY; MONOAMINE METABOLISM; NONHUMAN; OVARIECTOMY; PARALLEL DESIGN; POSTMENOPAUSE; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIAL BEHAVIOR; STEROID RELEASE; TELEMETRY; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; AGGRESSION; ANIMALS; CROSS-OVER STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HYDROCORTISONE; INTRAUTERINE DEVICES, MEDICATED; MACACA FASCICULARIS; MEDROXYPROGESTERONE 17-ACETATE; MOTOR ACTIVITY; OVARIECTOMY; PLACEBOS; POSTMENOPAUSE; PROGESTERONE; RANDOM ALLOCATION; SOCIAL BEHAVIOR;

EID: 36049015832     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.07.002     Document Type: Article

References (33)

1. Agrimonti F., Angeli A., Frairia R., Fazzari A., Tamagnone C., Fornaro D., and Ceresa F. Circannual rhythmicities of cortisol levels in the peripheral plasma of healthy subjects. Chronobiologia 9 2 (1982) 107-114
2. Altmann J. Observational study of behavior: sampling methods. Behaviour 48 (1974) 1-41
3. Bjorn I., Bixo M., Nojd K.S., Collberg P., Nyberg S., Sundstrom-Poromaa I., and Backstrom T. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol. Endocrinol. 16 (2002) 1-8
4. Bjorn I., Bixo M., Nojd K.S., Nyberg S., and Backstrom T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am. J. Obstet. Gynecol. 183 (2000) 1419-1426
5. Cicinelli E., Borraccino V., Petruzzi D., Mazzotta N., Cerundolo M.L., and Schonauer L.M. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil. Steril. 65 (1996) 860-862
6. Conover W.J., and Iman R.L. Rank transformations as a bridge between parametric and nonparametric statistics. The American Statistician 35 (1981) 120-124
7. Fanchin R., De Ziegler D., Bergeron C., Righini C., Torrisi C., and Frydman R. Transvaginal administration of progesterone. Obstet. Gynecol. 90 (1997) 396-401
8. Gilardi K.V., Shideler S.E., Valverde C.R., Roberts J.A., and Lasley B.L. Characterization of the onset of menopause in the rhesus macaque. Biol. Reprod. 57 (1997) 335-340
9. Hall M.E., Hoffer B.J., and Gerhardt G.A. Rapid and sensitive determination of catecholamines in small tissue samples by high performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. L.C./G.C. 7 3 (1989) 258-265
10. Hamada A.L., Maruo T., Samoto T., Yoshida S., Nash H., Spitz I.M., and Johansson E. Estradiol/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women. Gynecol. Endocrinol. 17 (2003) 247-254
11. Johansson E.D., and Sitruk-Ware R. New delivery systems in contraception: vaginal rings. Am. J. Obstet. Gynecol. 190 (2004) S54-S59
12. Kaunitz A.M. Injectable long-acting contraceptives. Clin. Obstet. Gynecol. 44 (2001) 73-91
13. Kavanagh K., Williams J.K., and Wagner J.D. Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status. J. Med. Primatol. 34 (2005) 171-177
14. Levine H., and Watson N. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertil. Steril. 73 (2000) 516-521
15. Lobo R.A., and Cassidenti D.L. Pharmacokinetics of oral 17 beta-estradiol. J. Reprod. Med. 37 (1992) 77-84
16. Maestripieri D., Schino G., Aureli F., and Troisi A. A modest proposal: displacement activities as an indicator of emotions in primates. Anim. Behav. 44 (1992) 967-979
17. Magness C.L., Fellin P.C., Thomas M.J., Korth M.J., Agy M.B., Proll S.C., Fitzgibbon M., Scherer C.A., Miner D.G., Katze M.G., and Iadonato S.P. Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human. Genome Biol. 6 (2005) R60
18. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 4753 (1986) 1004-1007
19. Maruo T., Mishell D.R., Ben-Chetrit A., Hochner-Celnikier D., Hamada A.L., and Nash H.A. Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy. Fertil. Steril. 78 (2002) 1010-1016
20. Maxson W.S., and Hargrove J.T. Bioavailability of oral micronized progesterone. Fertil. Steril. 44 (1985) 622-626
21. Mircioiu C., Perju A., Neagu A., Griu E., Calin G., and Miron D.S. Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration. Eur. J. Drug Metab. Pharmacokinet. 23 (1998) 391-396
22. Pasquale S.A., Foldesy R.G., Levine J.P., Bachmann G.A., and Blackwell R.E. Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women. Fertil. Steril. 68 (1997) 810-815
23. Patacchioli F.R., Simeoni S., Monnazzi P., Pace M., Capri O., and Perrone G. Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HRT). Maturitas 55 (2006) 150-155
24. Pazol K., Wilson M.E., and Wallen K. Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques. J. Clin. Endocrinol. Metab. 89 (2004) 2998-3006
25. Pripp U., Schenck-Gustafsson K., Landgren B.M., and Carlstrom K. Circulating concentrations of hemostatic factors and two "steroid sensitive proteins" during oral hormone replacement therapy in women with coronary heart disease. Scand. J. Clin. Lab. Invest. 64 (2004) 659-665
26. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72 (1991) 336-343
27. Shively C.A., and Kaplan J.R. Stability of social status rankings of female cynomolgus monkeys, of varying reproductive condition, in different social groups. Am. J. Primatol. 23 (1991) 239-245
28. Shively C.A., Kaplan J.R., and Adams M.R. Effects of ovariectomy, social instability and social status on female Macaca fascicularis social behavior. Physiol. Behav. 36 (1986) 1147-1153
29. Shively C.A., Register T.C., Friedman D.P., Morgan T.M., Thompson J., and Lanier T. Social stress-associated depression in adult female cynomolgus monkeys (Macaca fascicularis). Biol. Psychol. 69 (2005) 67-84
30. Singh M. Progesterone-induced neuroprotection. Endocrine 29 (2006) 271-274
31. van Broekhoven F., Backstrom T., and Verkes R.J. Oral progesterone decreases saccadic eye velocity and increases sedation in women. Psychoneuroendocrinology 31 (2006) 1190-1199
32. Wood C.E., Register T.C., Lees C.J., Chen H., Kimrey S., and Cline M.J. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res. Treat. 101 (2007) 125-134
33. Wood C.E., Sitruk-Ware R.L., Tsong Y.-Y., Register T.C., Lees C.J., and Cline J.M. Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model. Menopause 14 (2007) 1-9